Antiviral Peptides
Explore peptide research and guides on antiviral peptides.
Boceprevir and Telaprevir: HCV's Peptide Protease Inhibitors
How two peptidomimetic drugs transformed hepatitis C treatment in 2011, achieved 70% cure rates, then were replaced within three years by superior antivirals.
Antiviral PeptidesBroad-Spectrum Antiviral Peptides Explained
Antiviral peptides target multiple viruses through membrane disruption and fusion inhibition. Review of defensins, LL-37, EK1C4, and temporins.
Antiviral PeptidesHow Lactoferricin Fights Viruses Across Multiple Families
Lactoferricin blocks viral entry by binding heparan sulfate, disrupts intracellular trafficking, and activates innate immunity against HSV, HIV, HCV, and more.
Antiviral PeptidesLL-37 and Influenza: Your Cathelicidin vs the Flu
LL-37, the human cathelicidin peptide, directly disrupts influenza viral membranes and reduces disease severity comparable to zanamivir in animal models.
Antiviral PeptidesMelittin: How Bee Venom Disrupts Virus Membranes
Melittin, the main peptide in bee venom, shows antiviral activity against HIV, herpes, and influenza by punching holes in viral envelopes.